{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:35:54Z","timestamp":1783632954175,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,2,16]]},"DOI":"10.1038\/onc.2016.264","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T10:10:56Z","timestamp":1471255856000},"page":"979-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["mTOR promotes pituitary tumor development through activation of PTTG1"],"prefix":"10.1038","volume":"36","author":[{"given":"R","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,15]]},"reference":[{"key":"BFonc2016264_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","volume":"4","author":"SL Asa","year":"2009","unstructured":"Asa SL, Ezzat S . The pathogenesis of pituitary tumors. Annu Rev Pathol 2009; 4: 97\u2013126.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2016264_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2012.143","volume":"8","author":"NF Marko","year":"2012","unstructured":"Marko NF, Weil RJ . Pituitary gland: new pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol 2012; 8: 572\u2013573.","journal-title":"Nat Rev Endocrinol"},{"key":"BFonc2016264_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed S . Pathogenesis of pituitary tumors. Nat Rev Endocrinol 2011; 7: 257\u2013266.","journal-title":"Nat Rev Endocrinol"},{"key":"BFonc2016264_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0079-6123(10)82009-6","volume":"182","author":"R Yu","year":"2010","unstructured":"Yu R, Melmed S . Pathogenesis of pituitary tumors. Prog Brain Res 2010; 182: 207\u2013227.","journal-title":"Prog Brain Res"},{"key":"BFonc2016264_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4: 648\u2013657.","journal-title":"Nat Cell Biol"},{"key":"BFonc2016264_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 2002; 11: 525\u2013534.","journal-title":"Hum Mol Genet"},{"key":"BFonc2016264_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC . Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell 2002; 10: 151\u2013162.","journal-title":"Mol Cell"},{"key":"BFonc2016264_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ncb840","volume":"4","author":"CJ Potter","year":"2002","unstructured":"Potter CJ, Pedraza LG, Xu T . Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002; 4: 658\u2013665.","journal-title":"Nat Cell Biol"},{"key":"BFonc2016264_CR9","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1158\/0008-5472.CAN-08-0922","volume":"68","author":"CH Squarize","year":"2008","unstructured":"Squarize CH, Castilho RM, Gutkind JS . Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res 2008; 68: 7066\u20137072.","journal-title":"Cancer Res"},{"key":"BFonc2016264_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","volume":"45","author":"RP Carson","year":"2012","unstructured":"Carson RP, Van Nielen DL, Winzenburger PA, Ess KC . Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis 2012; 45: 369\u2013380.","journal-title":"Neurobiol Dis"},{"key":"BFonc2016264_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","volume":"20","author":"AJ Malhowski","year":"2011","unstructured":"Malhowski AJ, Hira H, Bashiruddin S, Warburton R, Goto J, Robert B et al. Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Hum Mol Genet 2011; 20: 1290\u20131305.","journal-title":"Hum Mol Genet"},{"key":"BFonc2016264_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. New Engl J Med 2008; 358: 140\u2013151.","journal-title":"New Engl J Med"},{"key":"BFonc2016264_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. New Engl J Med 2011; 364: 1595\u20131606.","journal-title":"New Engl J Med"},{"key":"BFonc2016264_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1677\/ERC-09-0101","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Wlodek E, Leontiou CA, Igreja S, Cakir M, Teng M et al. Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 2009; 16: 1329\u20131338.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2016264_CR15","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-15-0288","volume":"21","author":"M Lee","year":"2015","unstructured":"Lee M, Wiedemann T, Gross C, Leinhauser I, Roncaroli F, Braren R et al. Targeting PI3K\/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas. Clin Cancer Res 2015; 21: 3204\u20133215.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016264_CR16","doi-asserted-by":"publisher","first-page":"R331","DOI":"10.1530\/ERC-14-0188","volume":"21","author":"E Monsalves","year":"2014","unstructured":"Monsalves E, Juraschka K, Tateno T, Agnihotri S, Asa SL, Ezzat S et al. The PI3K\/AKT\/mTOR pathway in the pathophysiology and treatment of pituitary adenomas. Endocr Relat Cancer 2014; 21: R331\u2013R344.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2016264_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-012-9682-3","volume":"42","author":"H Rubinfeld","year":"2012","unstructured":"Rubinfeld H, Shimon I . PI3K\/Akt\/mTOR and Raf\/MEK\/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocrine 2012; 42: 285\u2013291.","journal-title":"Endocrine"},{"key":"BFonc2016264_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-015-1895-x","volume":"125","author":"R Xie","year":"2015","unstructured":"Xie R, He WQ, Shen M, Shou XF, Wang YF, Bao WM et al. Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells. J Neurooncol 2015; 125: 79\u201389.","journal-title":"J Neurooncol"},{"key":"BFonc2016264_CR19","doi-asserted-by":"crossref","first-page":"39329","DOI":"10.18632\/oncotarget.5744","volume":"6","author":"SJ Lin","year":"2015","unstructured":"Lin SJ, Leng ZG, Guo YH, Cai L, Cai Y, Li N et al. Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline. Oncotarget 2015; 6: 39329\u201339341.","journal-title":"Oncotarget"},{"key":"BFonc2016264_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/mend.11.4.9911","volume":"11","author":"L Pei","year":"1997","unstructured":"Pei L, Melmed S . Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997; 11: 433\u2013441.","journal-title":"Mol Endocrinol"},{"key":"BFonc2016264_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1126\/science.285.5426.418","volume":"285","author":"H Zou","year":"1999","unstructured":"Zou H, McGarry TJ, Bernal T, Kirschner MW . Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999; 285: 418\u2013422.","journal-title":"Science"},{"key":"BFonc2016264_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1210\/me.2004-0403","volume":"19","author":"RA Abbud","year":"2005","unstructured":"Abbud RA, Takumi I, Barker EM, Ren SG, Chen DY, Wawrowsky K et al. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 2005; 19: 1383\u20131391.","journal-title":"Mol Endocrinol"},{"key":"BFonc2016264_CR23","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1210\/en.2006-0544","volume":"147","author":"I Donangelo","year":"2006","unstructured":"Donangelo I, Gutman S, Horvath E, Kovacs K, Wawrowsky K, Mount M et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 2006; 147: 4781\u20134791.","journal-title":"Endocrinology"},{"key":"BFonc2016264_CR24","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1210\/me.2005-0137","volume":"19","author":"V Chesnokova","year":"2005","unstructured":"Chesnokova V, Kovacs K, Castro AV, Zonis S, Melmed S . Pituitary hypoplasia in Pttg-\/- mice is protective for Rb+\/- pituitary tumorigenesis. Mol Endocrinol 2005; 19: 2371\u20132379.","journal-title":"Mol Endocrinol"},{"key":"BFonc2016264_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/15275","volume":"5","author":"AP Heaney","year":"1999","unstructured":"Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S . Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999; 5: 1317\u20131321.","journal-title":"Nat Med"},{"key":"BFonc2016264_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","volume":"84","author":"X Zhang","year":"1999","unstructured":"Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 1999; 84: 761\u2013767.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFonc2016264_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12032-010-9775-x","volume":"29","author":"ZZ Feng","year":"2012","unstructured":"Feng ZZ, Chen JW, Yang ZR, Lu GZ, Cai ZG . Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression. Med Oncol 2012; 29: 304\u2013310.","journal-title":"Med Oncol"},{"key":"BFonc2016264_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0140-6736(99)10238-1","volume":"355","author":"AP Heaney","year":"2000","unstructured":"Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S . Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000; 355: 716\u2013719.","journal-title":"Lancet"},{"key":"BFonc2016264_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR . A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49\u201354.","journal-title":"Nat Genet"},{"key":"BFonc2016264_CR30","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1210\/me.2006-0280","volume":"20","author":"G Vlotides","year":"2006","unstructured":"Vlotides G, Cruz-Soto M, Rubinek T, Eigler T, Auernhammer CJ, Melmed S . Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT\/GF cells. Mol Endocrinol 2006; 20: 3321\u20133335.","journal-title":"Mol Endocrinol"},{"key":"BFonc2016264_CR31","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.febslet.2005.05.008","volume":"579","author":"AD Thompson 3rd","year":"2005","unstructured":"Thompson AD 3rd, Kakar SS . Insulin and IGF-1 regulate the expression of the pituitary tumor transforming gene (PTTG) in breast tumor cells. FEBS Lett 2005; 579: 3195\u20133200.","journal-title":"FEBS Lett"},{"key":"BFonc2016264_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/er.2006-0042","volume":"28","author":"G Vlotides","year":"2007","unstructured":"Vlotides G, Eigler T, Melmed S . Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 2007; 28: 165\u2013186.","journal-title":"Endocr Rev"},{"key":"BFonc2016264_CR33","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.1158\/0008-5472.CAN-06-1895","volume":"66","author":"J Yu","year":"2006","unstructured":"Yu J, Henske EP . Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Cancer Res 2006; 66: 9461\u20139466.","journal-title":"Cancer Res"},{"key":"BFonc2016264_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/dvg.20362","volume":"46","author":"Z Yin","year":"2008","unstructured":"Yin Z, Williams-Simons L, Rawahneh L, Asa S, Kirschner LS . Development of a pituitary-specific cre line targeted to the Pit-1 lineage. Genesis 2008; 46: 37\u201342.","journal-title":"Genesis"},{"key":"BFonc2016264_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gene.10036","volume":"32","author":"R Lesche","year":"2002","unstructured":"Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H et al. Cre\/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002; 32: 148\u2013149.","journal-title":"Genesis"},{"key":"BFonc2016264_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007; 448: 439\u2013444.","journal-title":"Nature"},{"key":"BFonc2016264_CR37","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1007\/s13277-015-3420-4","volume":"36","author":"M Liang","year":"2015","unstructured":"Liang M, Liu J, Ji H, Chen M, Zhao Y, Li S et al. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K\/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo. Tumour Biol 2015; 36: 7085\u20137091.","journal-title":"Tumour Biol"},{"key":"BFonc2016264_CR38","doi-asserted-by":"crossref","unstructured":"Lin YH, Tian Y, Wang JS, Jiang YG, Luo Y, Chen YT . Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13. Tumour Biol 2015, e-pub ahead of print 23 July 2015.","DOI":"10.1007\/s13277-015-3796-1"},{"key":"BFonc2016264_CR39","doi-asserted-by":"publisher","first-page":"19516","DOI":"10.1074\/jbc.M111.337428","volume":"287","author":"CH Yoon","year":"2012","unstructured":"Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ, Yoo KC et al. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem 2012; 287: 19516\u201319527.","journal-title":"J Biol Chem"},{"key":"BFonc2016264_CR40","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1172\/JCI60417","volume":"121","author":"H Fukuoka","year":"2011","unstructured":"Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D et al. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest 2011; 121: 4712\u20134721.","journal-title":"J Clin Invest"},{"key":"BFonc2016264_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1677\/ERC-08-0167","volume":"16","author":"Y Lin","year":"2009","unstructured":"Lin Y, Jiang X, Shen Y, Li M, Ma H, Xing M et al. Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors. Endocr Relat Cancer 2009; 16: 301\u2013310.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2016264_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1677\/erc.1.00949","volume":"12","author":"M Musat","year":"2005","unstructured":"Musat M, Korbonits M, Kola B, Borboli N, Hanson MR, Nanzer AM et al. Enhanced protein kinase B\/Akt signalling in pituitary tumours. Endocr Relat Cancer 2005; 12: 423\u2013433.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2016264_CR43","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/onc.2012.190","volume":"32","author":"T Palumbo","year":"2013","unstructured":"Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA . Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene 2013; 32: 1651\u20131659.","journal-title":"Oncogene"},{"key":"BFonc2016264_CR44","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1038\/sj.onc.1205428","volume":"21","author":"M Fedele","year":"2002","unstructured":"Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJ et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002; 21: 3190\u20133198.","journal-title":"Oncogene"},{"key":"BFonc2016264_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2006.04.024","volume":"9","author":"M Fedele","year":"2006","unstructured":"Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006; 9: 459\u2013471.","journal-title":"Cancer Cell"},{"key":"BFonc2016264_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2010.03.019","volume":"326","author":"M Fedele","year":"2010","unstructured":"Fedele M, Palmieri D, Fusco A . HMGA2: A pituitary tumour subtype-specific oncogene? Mol Cell Endocrinol 2010; 326: 19\u201324.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2016264_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fonc.2014.00203","volume":"4","author":"DA Cano","year":"2014","unstructured":"Cano DA, Soto-Moreno A, Leal-Cerro A . Genetically engineered mouse models of pituitary tumors. Front Oncol 2014; 4: 203.","journal-title":"Front Oncol"},{"key":"BFonc2016264_CR48","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/endo.140.11.7118","volume":"140","author":"SL Asa","year":"1999","unstructured":"Asa SL, Kelly MA, Grandy DK, Low MJ . Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999; 140: 5348\u20135355.","journal-title":"Endocrinology"},{"key":"BFonc2016264_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0896-6273(00)80351-7","volume":"19","author":"MA Kelly","year":"1997","unstructured":"Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 1997; 19: 103\u2013113.","journal-title":"Neuron"},{"key":"BFonc2016264_CR50","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/en.2002-220173","volume":"143","author":"ME Cruz-Soto","year":"2002","unstructured":"Cruz-Soto ME, Scheiber MD, Gregerson KA, Boivin GP, Horseman ND . Pituitary tumorigenesis in prolactin gene-disrupted mice. Endocrinology 2002; 143: 4429\u20134436.","journal-title":"Endocrinology"},{"key":"BFonc2016264_CR51","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1172\/JCI0215912","volume":"110","author":"KG Schuff","year":"2002","unstructured":"Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 2002; 110: 973\u2013981.","journal-title":"J Clin Invest"},{"key":"BFonc2016264_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2015.08.024","volume":"421","author":"KE Lines","year":"2016","unstructured":"Lines KE, Stevenson M, Thakker RV . Animal models of pituitary neoplasia. Mol Cell Endocrinol 2016; 421: 68\u201381.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2016264_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","volume":"57","author":"H Kenerson","year":"2005","unstructured":"Kenerson H, Dundon TA, Yeung RS . Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 2005; 57: 67\u201375.","journal-title":"Pediatr Res"},{"key":"BFonc2016264_CR54","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1210\/en.2007-1696","volume":"149","author":"C Lu","year":"2008","unstructured":"Lu C, Willingham MC, Furuya F, Cheng SY . Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors. Endocrinology 2008; 149: 3339\u20133345.","journal-title":"Endocrinology"},{"key":"BFonc2016264_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1677\/JOE-09-0232","volume":"203","author":"T Hikake","year":"2009","unstructured":"Hikake T, Hayashi S, Iguchi T, Sato T . The role of IGF1 on the differentiation of prolactin secreting cells in the mouse anterior pituitary. J Endocrinol 2009; 203: 231\u2013240.","journal-title":"J Endocrinol"},{"key":"BFonc2016264_CR56","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000070898","volume":"77","author":"G Pelletier","year":"2003","unstructured":"Pelletier G, Li S, Phaneuf D, Martel C, Labrie F . Morphological studies of prolactin-secreting cells in estrogen receptor alpha and estrogen receptor beta knockout mice. Neuroendocrinology 2003; 77: 324\u2013333.","journal-title":"Neuroendocrinology"},{"key":"BFonc2016264_CR57","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1210\/endo.140.9.6973","volume":"140","author":"L Stefaneanu","year":"1999","unstructured":"Stefaneanu L, Powell-Braxton L, Won W, Chandrashekar V, Bartke A . Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology 1999; 140: 3881\u20133889.","journal-title":"Endocrinology"},{"key":"BFonc2016264_CR58","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1172\/JCI28984","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL et al. PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR. J Clin Invest 2007; 117: 730\u2013738.","journal-title":"J Clin Invest"},{"key":"BFonc2016264_CR59","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1038\/onc.2012.481","volume":"32","author":"H Peng","year":"2013","unstructured":"Peng H, Liu J, Sun Q, Chen R, Wang Y, Duan J et al. mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development. Oncogene 2013; 32: 4702\u20134711.","journal-title":"Oncogene"},{"key":"BFonc2016264_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI37964","volume":"120","author":"J Ma","year":"2010","unstructured":"Ma J, Meng Y, Kwiatkowski DJ, Chen X, Peng H, Sun Q et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade. J Clin Invest 2010; 120: 103\u2013114.","journal-title":"J Clin Invest"},{"key":"BFonc2016264_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1158\/0008-5472.CAN-10-1668","volume":"71","author":"X Zha","year":"2011","unstructured":"Zha X, Wang F, Wang Y, He S, Jing Y, Wu X et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 2011; 71: 13\u201318.","journal-title":"Cancer Res"},{"key":"BFonc2016264_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/gcc.20118","volume":"42","author":"L Lee","year":"2005","unstructured":"Lee L, Sudentas P, Donohue B, Asrican K, Worku A, Walker V et al. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 2005; 42: 213\u2013227.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016264","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T21:05:50Z","timestamp":1647896750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,2,16]]}},"alternative-id":["BFonc2016264"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.264","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]},"assertion":[{"value":"17 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}